World ADC Digital
Join the World’s Premier Online Antibody Drug Conjugate Event
For over a decade, the World ADC team have been working closely with industry pioneers to bring you novel content, case studies and timely insights to help you stay ahead of the curve with the most cutting-edge ADC science. It is fantastic to see our community grow and continue to advance the development of antibody-drug conjugates helping forward thinking researchers from the pharmaceutical, biotech and academic institutes.
This year, to meet your needs in the new world, World ADC Digital gives you access to a greater breadth and depth of content from discovery through to process development and manufacturing as well as delving further into alternative formats and ADCs outside of oncology.
Join your peers for the 4-day virtual one-stop-shop for all things ADC where you will:
- Hear from Daiichi Sankyo, Seattle Genetics and Genentech as they share their journeys to getting their drugs on the market in 2019
- Join Bolt Bio, Mersana and Ambrx on their novel payload types sharing the story of immune-stimulatory ADCS
- Gain an update from Patrick Van Berckel at ADC Therapeutics on Loncastuximab tesirine with overview of the manufacturing strategy, the clinical data and more…
- Learn from Dario Neri the importance of Small molecule-drug conjugates (SMDCs) and ADCs: a comparative evaluation
…and lots more! You will need to look no further.
Our new, virtual platform will allow you to access high-quality content and networking opportunities live and direct from your home or office.